Melissa Soliz Educates American Bar Association on Changes to Health Privacy & Data Rules

Melissa Soliz Educates American Bar Association on Changes to Health Privacy & Data Rules

The health data landscape is rapidly changing, and Melissa Soliz recently helped members of the American Bar Association’s health law and science and technology law sections understand recent and upcoming developments. During the webinar, Mel focused on the status of CMS and ONC final rules on information blocking and interoperability as well as recent and upcoming modifications to the 42 CFR Part 2 rules governing substance use disorder information. This includes major changes that will, in specific cases, align Part 2 data sharing rules more closely to HIPAA. With extensive experience in regulatory health law, data privacy and patient access laws, Mel has educated numerous organizations about the Information Blocking Rule (IBR). Most recently, she shared her expertise during the Strategic Health Information Exchange Collaborative’s (SHIEC) webinar...

Read MoreRead More
Kristen Rosati Explains Complicated Web of Laws Regulating Privacy in Oncology Treatment and Research at National Cancer Policy Forum

Kristen Rosati Explains Complicated Web of Laws Regulating Privacy in Oncology Treatment and Research at National Cancer Policy Forum

Kristen Rosati addressed the National Academies of Science, Engineering and Medicine National Cancer Policy Forum workshop on the role of digital health applications in oncology research and care. Kristen’s presentation addressed legal considerations around patient privacy and data security, in digital health applications. One of the nation’s leading “Big Data” and HIPAA compliance attorneys, Kristen focused on how the patient right of access, the patient right to direct disclosures to third parties, and the new information blocking and interoperability rules affect oncology digital health apps. She also provided an overview of privacy requirements for data sharing in cancer treatment and research, discussing the evolving standards for de-identification of genomic information.  With deep experience in data sharing for research and clinical integration initiatives, clinical research compliance, and biobanking and genomic...

Read MoreRead More